Cencora, INC Form 4 insider transactions

Director Lauren M. Tyler reports acquiring 107 shares of Cencora, Inc. common stock on November 1, 2024, through a grant of restricted stock units.

Director Frank Clyburn acquired 368 shares of Cencora, Inc. common stock on November 1, 2024, at a price of $234.27 per share.

Steven H. Collis, Executive Chairman of Cencora Inc., reports the exercise of stock options and subsequent sale of shares under a pre-arranged trading plan.

Cencora's CEO, Steven H. Collis, exercised stock options and sold shares of common stock on September 17, 2024, according to a Form 4 filing with the SEC.

Cencora's CEO, Steven H. Collis, exercised stock options and sold shares of common stock on August 20, 2024, according to a Form 4 filing with the SEC.

Director Lon R. Greenberg reported a gift of 5,000 Cencora, Inc. shares to a charitable trust on August 5, 2024.

Silvana Battaglia, an Executive Vice President at Cencora, Inc., reported selling 1,473 shares of common stock on August 6, 2024.

Walgreens Boots Alliance continues to reduce its stake in Cencora, selling shares through both open market and private transactions.

Director Dennis M. Nally acquired 128 shares of Cencora, Inc. common stock on August 1, 2024, in lieu of a cash retainer.

Director Werner Baumann acquired 103 shares of Cencora, Inc. common stock on August 1, 2024, in lieu of a quarterly cash retainer.

Director Lauren M. Tyler acquired 103 shares of Cencora, Inc. common stock on August 1, 2024, in lieu of a $25,000 quarterly cash retainer.

Cencora's CEO, Steven H. Collis, exercised stock options and sold shares of common stock on July 16, 2024, according to a pre-arranged Rule 10b5-1 trading plan.

Silvana Battaglia, an Executive Vice President at Cencora, Inc., reported the purchase of common stock through the company's Employee Stock Purchase Plan on June 28, 2024.

Elizabeth S. Campbell, Executive Vice President at Cencora, Inc., acquired additional shares of common stock through the company's Employee Stock Purchase Plan on June 28, 2024.

Leslie E. Donato, EVP & Chief Strategy Officer of Cencora, Inc., acquired shares of common stock through the company's Employee Stock Purchase Plan on June 28, 2024.

Leslie E. Donato, EVP & Chief Strategy Officer of Cencora, Inc., reports the vesting of restricted stock units and subsequent disposition of shares to cover tax obligations.

Cencora's CEO, Steven Collis, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Gina Clark, Executive Vice President of Cencora, Inc., sold 1,874 shares of common stock at a price of $223.856 on May 31, 2024, leaving her with 13,284 shares.

Executive Vice President Gina Clark exercised stock options and sold shares of Cencora, Inc. on May 29, 2024, according to a recent SEC Form 4 filing.

Director D. Mark Durcan of Cencora, Inc. (COR) acquired 500 shares of common stock at a price of $218.58 on May 24, 2024, increasing his total holdings to 21,876 shares.

Walgreens Boots Alliance sold 1,859,390 shares of Cencora in a private transaction on May 22, 2024, reducing its beneficial ownership.

Steven H. Collis, Chairman, President & CEO of Cencora, Inc., reported the exercise of stock options and subsequent sale of shares under a pre-arranged Rule 10b5-1 trading plan.

Director Lon R. Greenberg reported gifting 2,000 shares of Cencora, Inc. common stock to a charitable trust on October 20, 2023.

Director Lauren M. Tyler acquired 110 shares of Cencora, Inc. common stock on May 1, 2024, at a price of $229.2 per share.

Director Werner Baumann acquired 110 shares of Cencora, Inc. common stock on May 1, 2024, in lieu of a $25,000 quarterly cash retainer.

Director Dennis M. Nally acquired 137 shares of Cencora Inc. common stock on May 1, 2024, in lieu of a cash retainer.

Executive Vice President & COO of Cencora, Robert P. Mauch, reports the acquisition and disposal of Cencora (COR) common stock and the exercise of non-qualified stock options.

Cencora's CEO, Steven Collis, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Cencora's CEO, Steven Collis, exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Executive Vice President Elizabeth S. Campbell of Cencora, Inc. reports the sale of 6,977 shares of common stock at a price of $238.12 per share on March 18, 2024.